Related Experiment Video
Updated: Sep 2, 2025
08:11
Measuring Progressive Neurological Disability in a Mouse Model of Multiple Sclerosis
Published on: November 14, 2016
11.1K
Summary
Early diagnosis and treatment are crucial for managing active progressive multiple sclerosis (MS). While challenges exist, disease-modifying therapies offer benefits, especially in younger patients with shorter disease duration.
Area of Science:
- Neurology
- Immunology
- Clinical Research
Background:
- Progressive multiple sclerosis (MS) encompasses primary progressive MS (PPMS) and secondary progressive MS (SPMS).
- Understanding the overlapping pathogenesis of PPMS and SPMS is key to effective management.
- Active progressive MS is characterized by relapses or MRI activity.
Purpose of the Study:
- To review current knowledge on progressive forms of multiple sclerosis.
- To highlight the importance of early diagnosis and intervention in progressive MS.
- To discuss treatment strategies and overall care for patients with progressive MS.
Main Methods:
- Review of current literature on progressive multiple sclerosis.
- Analysis of diagnostic challenges and progression factors.
- Evaluation of disease-modifying therapies for active progressive MS.
Main Results:
- Disease-modifying therapies are indicated for active secondary progressive MS.
- Therapeutic benefits are greater in younger patients with shorter disease duration.
- Vascular comorbidities may influence MS progression.
Conclusions:
- Early identification of active progressive MS is essential for maximizing treatment efficacy.
- Challenges in diagnosis, follow-up, and treatment persist.
- Guidelines for advanced MS care are needed.
Related Concept Videos
01:15Parkinson's Disease: Overview
687
Neurodegenerative disorders are progressive diseases that cause irreversible damage and loss to neurons in specific brain areas. Examples of these disorders include Parkinson's disease, Alzheimer's disease, Multiple Sclerosis (MS), and Amyotrophic Lateral Sclerosis (ALS). These disorders share characteristics such as proteinopathies, selective neuronal vulnerability, and a complex interplay between genetic and environmental factors. The primary therapeutic goal for these conditions is...
687
02:07Tumor Progression
6.5K
Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
6.5K